Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
7h
Starboard Focused on Kenvue's Struggling Unit
Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
BioSpace
20h
Activist Investor Starboard Takes Aim at J&J Spinoff Kenvue on Heels of $1B Stake in Pfizer
Starboard Value contends that Kenvue, with strong consumer health brands like Tylenol and Listerine, is underperforming its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Linked to E. coli outbreak
Arrested in trafficking case
Arlington visit records order
Lake Erie toxic algae study
MO court upholds release
To close 150 locations
2 US troops injured in raid
To appear on Rogan podcast
Trespassing charge upheld
Veteran film producer dies
Giant ‘ghost’ fish spotted
DOJ alleges racial bias
GA election rules appeal
FDA approves RSV vaccine
Six indicted for fraud in Ohio
FAA finalizes safety rules
Brain stimulation study
Raises US growth forecast
SK mulls arms for Ukraine
Same-day pharmacy delivery
Target to cut prices
Hospitals' IV fluid shortage
Probing leak of US intel
Ordered to hand over assets
2025 Medicare changes
US semiconductor tax credit
Infant mortality increased
To headline 2 Harris rallies
Right whale population rises
Reveals 2025 tax brackets
Related topics
Kenvue
Starboard
Johnson & Johnson
Listerine
The Wall Street Journal
Feedback